Tumour production in immunosuppressed rats with cells transformed in vitro by adenovirus type 2.
D000256:Adenoviridae / Q000254:growth & development*; D000818:Animals; D000961:Antilymphocyte Serum; D002471:Cell Transformation, Neoplastic; D002999:Clone Cells; D046508:Culture Techniques; D005260:Female; D005347:Fibroblasts / Q000382:microbiology; D005455:Fluorescent Antibody Technique; D006652:Histological Techniques; D007106:Immune Sera; D007165:Immunosuppression Therapy; D008297:Male; D009368:Neoplasm Transplantation; D011817:Rabbits / Q000276:immunology; D051381:Rats / Q000196:embryology; D012513:Sarcoma, Experimental / Q000382:microbiology*; D016038:Skin Transplantation; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D007106:Immune Sera